Developmental Therapeutics is a broad area of study that includes basic research aimed at finding new targets for anticancer agents, preclinical testing of new drugs or cell and immune therapies for cancer treatment, and clinical trials to test new agents in people.
Developmental Therapeutics has been launched to accelerate the translation of preclinical science breakthroughs so as to develop better therapies for our patients.
New approaches are being used to prevent cancer, better predict its causes and improve its treatment. Developmental Therapeutics will be offering patients the most advanced clinical trial and treatment options available.
Our ability to call upon the world-class resources of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, a National Cancer Institute (NCI)-designated Comprehensive Cancer Center, the research and medical expertise of the Northwestern University Feinberg School of Medicine and Northwestern Medical Group, and the preeminent healthcare facilities of Northwestern Memorial Hospital allows Developmental Therapeutics to provide patients with the best possible care.
News & Events
Developmental Therapeutics opens, offering novel therapeutic approaches for the treatment of cancer and other life-threatening diseases.
Meet Our Team
Areas of Clinical Expertise